Company scheduled to make major product announcement.
(New York, NY) September 23, 2003 – Kyowa Hakko U.S.A., a world leader in the development, manufacturing and marketing of pharmaceuticals, nutraceuticals and food products, will make a major announcement regarding its Citicoline ingredient as well as sponsor a seminar featuring the Recently Discovered Health Benefits of Citicoline at the SupplySide West VendorWorks in Las Vegas, Thursday, October 2, at Noon, at the Venetian Hotel/Sands Expo, room 803-804. Keynote speaker is Dr. Alexander G. Schauss, PhD, director, Natural and Medicinal Products Research, Life Sciences Division, American Institute for Biosocial and Medical Research Inc., and leading scientific expert on the health benefits of Citicoline. Attendees with Expo Only badges are welcome for VendorWorks presentations.
Citicoline is a novel and powerful anti-aging ingredient that has been used significantly in the treatment of neurodegenerative disorders associated with stroke, cerebrovascular pathology, brain aging and head trauma.
Kyowa Hakko has developed new commercial production techniques of Citicoline using fermentation technology. Scientific studies have indicated effectiveness in treating Alzheimer’s and Parkinson’s disease and improved stroke recuperation, as well as glaucoma.
In addition to the Kyowa Hakko U.S.A. product announcmeent, Dr. Schauss will discuss the capabilities Citicoline has shown in reversing memory loss and its ability to mitigate cardiovascular pathologies such as stroke which contributes to the loss of brain function.
To make a reservation for this seminar and sushi luncheon, please call (800) 570-1262. Visit Kyowa Hakko U.S.A. at booth #1320.
# # # #